Press Releases
SAN DIEGO, Oct. 15, 2019 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that Craig Thompson, president and chief executive officer, will present at the Solebury Trout Private Company Showcase, on Friday, October 18
Read more...15 October 2019
OAKLAND, CA and TORONTO, Oct. 15, 2019 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company") (CSE: HBOR), a California-focused, vertically integrated cannabis enterprise, announced today that key executives, members of the Board of Directors and insiders, have entered into an additional, extended
Read more...15 October 2019
CLACKAMAS, Ore., Oct. 15, 2019 /PRNewswire/ -- Today, Oregon-based Health Wright Products (HWP) announced the completion of phase one of i
Read more...MENLO PARK, Calif., Oct. 15, 2019 /PRNewswire/ -- Subtle Medical, a healthcare technology company focused on improving the quality, efficiency, and accessibility of medical imaging, announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtleMRTM. SubtleMR is an image processing software that uses denoising and resolution
Read more...Nextleaf Labs is designed to process more than 270,000 kg of dried cannabis and hemp biomass per year using Nextleaf Solutions' patented intellectual property VANCOUVER, Oct. 15, 2019 /PRNewswire/ - Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) a
Read more...15 October 2019
DUBLIN, Oct. 15, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its third quarter calendar year 2019 financial results on Wednesday, November 6, 2019. The Company will host a conference call beginning at 8:00 a.m. (EDT).
Read more...15 October 2019
Strainprint Analytics Research Platform to Help Support Canadian Government Policies Post-Cannabis Legalization TORONTO, Oct. 15, 2019 /PRNewswire/ -
Read more...SOUTH SAN FRANCISCO, Calif., Oct. 15, 2019 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis, announced the publication of a study evaluating the use of a positron emission tomography (PET) tracer for the detection of idiopathic pulmonary fibrosis
Read more...15 October 2019
DAVIS, Calif., Oct. 15, 2019 /PRNewswire/ -- The National Institute on Drug Abuse (NIDA) has awarded a grant to EicOsis LLC as part of the NIH initiati
Read more...REDWOOD SHORES, Calif., Oct. 15, 2019 /PRNewswire/ -- Taking a new people-centric approach to providing support and care, Oracle offers new services to citizens in need. New digital case management capabilities, now available in
Read more...